Product
[225Ac]-FPI-1434
Aliases
[225Ac]-FPI-1434 Injection multi-dose, [225Ac]-FPI-1434 Injection single-dose
1 clinical trial
9 indications
Indication
Cervical CancerIndication
Ovarian CancerIndication
Breast CancerIndication
Triple Negative Breast CancerIndication
Head and Neck Squamous Cell CarcinomaIndication
Adrenocortical CancerIndication
Uveal melanomaIndication
Advanced Solid TumoursIndication
Endometrial CancerClinical trial
A Phase 1/2 Study of [225Ac]-FPI-1434 Injection in Patients With Locally Advanced or Metastatic Solid TumoursStatus: Recruiting, Estimated PCD: 2024-06-01